A Clinical Case of Fertility Preservation in an Adolescent with Hodgkin Lymphoma

  • Mohamed Khrouf
  • Marouen Braham
  • Selim Khrouf
  • Fehmi Msaddak


NT is a 15-year-old post-menarchal girl; she was complaining of cervical enlargement, a weight loss of 21 kg in 3 months, night sweats, and fever. Clinical examination of the patient found a 2 cm fixed painless and firm right lateral jugular lymphadenopathy. The left cervical lymphadenopathy biopsy revealed a scleronodular Hodgkin’s disease. The patient’s disease was staged IIBb with mediastinal bulky according to the Ann Arbor classification system.


Oncofertility Fertility preservation Adolescent fertility preservation Hodgkin lymphoma Perurethral transvesical pickup 


  1. 1.
    Lekovich J, Lobel ALS, Stewart JD, Pereira N, Kligman I, Rosenwaks Z. Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies. J Assist Reprod Genet. 2016;33:657–62. Scholar
  2. 2.
    Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online. 2010;20:280–5. Scholar
  3. 3.
    Anderson RA, Rosendahl M, Kelsey TW, Cameron DA. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. Eur J Cancer. 2013;49:3404–11. Scholar
  4. 4.
    Diaz-Garcia C, Domingo J, Garcia-Velasco JA, Herraiz S, Mirabet V, Iniesta I, Cobo A, Remohí J, Pellicer A. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018;109:478–485.e2. Scholar
  5. 5.
    Van der Ven H, Liebenthron J, Beckmann M, Toth B, Korell M, Krüssel J, Frambach T, Kupka M, Hohl MK, Winkler-Crepaz K, Seitz S, Dogan A, Griesinger G, Häberlin F, Henes M, Schwab R, Sütterlin M, von Wolff M, Dittrich R, FertiPROTEKT network. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod Oxf Engl. 2016;31:2031–41. Scholar
  6. 6.
    Dolmans M-M, Luyckx V, Donnez J, Andersen CY, Greve T. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013;99:1514–22. Scholar
  7. 7.
    Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2013;31:2500–10. Scholar
  8. 8.
    Massin N. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Updat. 2017;23:211–20. Scholar
  9. 9.
    Khrouf M, Braham M, Bouyahia M, Kacem-Berejeb K, Elloumi-Chaabane H, Zhioua A, Zhioua F. Perurethraltransvesical route for oocytes retrieval: an old technique for a new indication in oncofertility. Future Oncol Lond Engl. 2017;13:2547–53. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Mohamed Khrouf
    • 1
  • Marouen Braham
    • 2
  • Selim Khrouf
    • 3
  • Fehmi Msaddak
    • 4
  1. 1.FERTILLIA ART center of Clinique La RoseTunisTunisia
  2. 2.ART center of Aziza Othmana Public HospitalTunisTunisia
  3. 3.Hopital Abderrahmane MamiTunisTunisia
  4. 4.Hematology DepartmentMilitary Hospital of Tunis, Faculté de Médecine de TunisTunisTunisia

Personalised recommendations